Korean J Med > Volume 77(2); 2009 > Article
The Korean Journal of Medicine 2009;77(2):403-406.
A case of thymic hyperplasia after immunochemotherapy in a patient with diffuse large B-cell lymphoma
Hoon Choi, Soon Il Lee, Geun Woo Park, So Mi Kim, Ran Noh, Ji Hyun Suh, Jai Hyuen Lee
악성 림프종 환자의 면역화학요법 후 발생한 흉선과형성 1예
최 훈, 이순일, 박건우, 김소미, 노 란, 서지현, 이재현
Abstract
Thymic hyperplasia can occur in various malignancies after cytotoxic chemotherapy. A possible cause is rebound enlargement after the initial atrophy caused by these drugs. We believe that this is an important issue in the treatment of malignancies. We confirmed this phenomenon using follow-up chest computed tomography (CT) and 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in a case of thymic hyperplasia after immunochemotherapy for B-cell lymphoma. Awareness of this benign condition can prevent unnecessary invasive procedures.
Key Words: Thymic hyperplasia; B-cell lymphoma


TOOLS
METRICS Graph View
  • 1,337 View
  • 2 Download

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next